Skip to content
★ Sign in to follow
KL

KCK Ltd.

Related company / holding
Insider activity · 24 months0 buys1 saleCumulative net flow
Total declarations
39
Companies
3
▲ Purchases (1 ops.)
€2.6M
▼ Sales (35 ops.)
€49.5M

Latest filing published 20 Feb 2025 for NeuroPace Inc, €47.5M.

Filing timeline

BuySale
KCK Ltd.

Insider track record

Disclosed buys
1
Disclosed sells
35

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

KCK Ltd.: trading record in brief

KCK Ltd. is a declared insider at 3 companies; the most frequent names are NeuroPace Inc, Rein Therapeutics, Inc. and Sight Sciences, Inc. The record holds 39 filings, for trades running from 5 July 2017 to 20 February 2025.

In open-market terms, that means 1 purchase worth €2.6M on one side and 35 sales worth €49.5M on the other. On balance, insiders were net sellers of €46.8M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2025 to date brings no purchases and 1 sale.

Most recently, on 20 February 2025, the filings show an open-market sale worth €47.5M in NeuroPace Inc. The last purchase on record was published on 5 July 2017, which is 3,414 days ago. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to KCK Ltd.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations9 total
  • ▼
    Related company / holdingExecutivesNeuroPace Inc
    50M USD25SEC
    5,270,845 shares@ US$9.4099.6% of flowCommon StockSEC:0001657662-25-000003:0
  • ▼
    Related company / holdingExecutivesNeuroPace Inc
    885 USD5SEC
    147 shares@ US$6.020.0% of flowCommon StockSEC:0001657662-24-000007:0
  • ▼
    Related company / holdingExecutivesNeuroPace Inc
    24,853 USD5SEC
    4,082 shares@ US$6.08850.0% of flowCommon StockSEC:0001657662-24-000006:0
  • ▼
    Related company / holdingExecutivesNeuroPace Inc
    30,692 USD5SEC
    4,878 shares@ US$6.29190.1% of flowCommon StockSEC:0001657662-24-000005:0
  • ▼
    Related company / holdingExecutivesNeuroPace Inc
    23,115 USD5SEC
    3,318 shares@ US$6.96650.0% of flowCommon StockSEC:0001657662-24-000004:0
  • ▼
    Related company / holdingExecutivesNeuroPace Inc
    33,477 USD5SEC
    4,314 shares@ US$7.760.1% of flowCommon StockSEC:0001062993-24-017384:0
  • ▼
    Related company / holdingExecutivesNeuroPace Inc
    49,216 USD17SEC
    5,644 shares@ US$8.720.1% of flowCommon StockSEC:0001062993-23-021754:0
  • ▼
    Related company / holdingExecutivesNeuroPace Inc
    58,150 USD17SEC
    6,490 shares@ US$8.960.1% of flowCommon StockSEC:0000950170-23-066847:0
  • ●
    Related company / holdingExecutivesSight Sciences, Inc.
    0SEC
    4,776,232 sharesCommon StockSEC:0001062993-21-006636:0

9 of 9 declarations